TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PHARMACO

OncologyInfectious DiseaseImmunology
Pharma

PHARMACO is a pharmaceutical company focused on Oncology, Infectious Disease, Immunology. Key products include SERTRALINE HYDROCHLORIDE.

1976
Since
6
Drugs
-
Trials
113
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 40%
0 drugs Phase 3: 8 Phase 2: 15 Phase 1: 68
Infectious Disease 27%
0 drugs Phase 3: 8 Phase 2: 18 Phase 1: 19
Immunology 13%
1 drugs Phase 3: 4 Phase 2: 8 Phase 1: 6
Metabolic 11%
0 drugs Phase 3: 5 Phase 2: 3 Phase 1: 10
Cardiovascular 9%
0 drugs Phase 3: 6 Phase 2: 1 Phase 1: 3

Pipeline Strength Pro

Loading...

Competitors Pro

Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Immunology
AstraZeneca big-pharma
Oncology, Cardiovascular, Metabolic, Immunology
Pfizer big-pharma
Oncology, Infectious Disease, Immunology